Abstract:Background: Oligo-astheno-teratospermia (sperm of low concentration, reduced motility and increased abnormal morphology)of unknown cause is common and the need for treatment is felt by patients and doctors alike. As a result, a variety of empirical, non-specific treatments have been used in an attempt to improve semen characteristics and fertility.Whilst bromocriptine treatment for reducing prolactin levels in hyperprolactinaemic males (as in females), and, in the treatment of hypogonadotropic hypogonadism with hyperprolactinaemia, is beneficial, it has also been used for oligospermic men in the absence of any endocrinopathy. Prolactin may play a direct role in spermatogenesis and hormone production. It has also been claimed that in oligospermic men with normal gonadotrophins mean prolactin levels are higher and that hyperprolactinaemia is more common compared to fertile men. It has been proposed that the administration of bromocriptine under these circumstances might counteract a prolactin-induced block on the action of gonadotrophins on the testicles and, subsequently, that the reduction in prolactin levels might lead to an improvement in semen parameters and fertility. Although it is not licensed for use in male infertility, bromocriptine has been used for normogonadotrophic individuals with oligospermia and normal or slightly elevated prolactin levels. This review considers the available evidence of the effect of bromocriptine therapy for normoprolactinaemic males with idiopathic oligo and/or asthenospermia. Objectives: The objective of this review was to assess the effects of bromocriptine on pregnancy rates among couples where subfertility has been attributed to idiopathic oligo- and/or asthenospermia. Search strategy: The Cochrane Subfertility Review Group specialised register of controlled trials was searched". Selection criteria: Randomised trials of oral bromocriptine versus placebo or no treatment for couples with subfertility attributed to male factor. Data collection and analysis: Data were extracted by one reviewer and any disagreements were resolved by discussion with other reviewers. Main results: Four studies were included. The method of randomisation was not specified in any of the trials, which were all of crossover design. Compared with placebo, bromocriptine was associated with a significant reduction in serum prolactin levels (weighted mean difference -195.3 micro international units per litre, 95% confidence interval -276.5 to -114). No effects on sperm parameters were seen. There was also no effect on pregnancy rates observed between bromocriptine and placebo (0.70 odds ratio, 95% confidence interval 0.15 to 3.24). Authors' conclusions: Bromocriptine appears to reduce prolactin levels in subfertile men with normal gonadotrophic function. There is not enough evidence to show that bromocriptine is helpful in improving fertility.[This abstract was prepared centrally.].

Male Infertility Associated With Hyperprolactinaemia: Our Experience Using Bromocriptine in University of Maiduguri Teaching Hospital North Eastern Nigeria

Hyperprolactinaemia: analysis of presentation, diagnosis and treatment in the endocrine service of a general hospital

WITHDRAWN: Bromocriptine for idiopathic oligo/asthenospermia

Bromocriptine for idiopathic oligo/asthenospermia

Effect of High-Dose Cabergoline Therapy for Hyperprolactinemic Infertility among Bangladeshi Women

Achievement of fertility in an infertile man with resistant macroprolactinoma using high-dose bromocriptine and a combination of human chorionic gonadotropin and an aromatase inhibitor

Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri

[Effects of bromocriptine on the treatment of prolactinomas in male patients and its influences on their sexual function]

[Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia]

Lack of effect of bromocriptine on semen quality in men with normal or slightly elevated prolactin levels

The effects of combined bromocriptine and Bu-shen-zhu-yun decoction on serum hormones, anxiety, and pregnancy in hyperprolactinemic infertility patients

The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia

Sexual Functioning in Hyperprolactinemic Patients Treated With Cabergoline or Bromocriptine

[Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction]

Treatment of sexual dysfunction induced by hyperprolactinemia accompanied by reduced luteinizing hormone levels: A case report

Demographic characteristics, presentations and treatment outcome of patients with prolactinoma

Clinical profile and early therapeutic response to cabergoline of patients with hyperprolactinemia in a Cameroonian population

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis

Treatment of hyperprolactinemia: a systematic review and meta-analysis

Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience